Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
PHASE3
This was a six-month open-label extension (OLE) study to evaluate the safet...
Use of a Product Containing the Cannabinoids CBD and THC as a Treatment Strategy for Alzheimer's Disease - Alzheimer's Disease and Cannabis Clinical Trial (DAZACANN) Open-Label Phase
PHASE1
Alzheimer's Disease (AD) has become a significant public health issue due t...
Status
Active Not Recruiting
Location
Universidade Federal da Integração Latino-Americana
A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects
PHASE1
To evaluate the effect of oral pH on the pharmacokinetics (PK) of a single ...